Causal association between celiac disease and inflammatory bowel disease: A two-sample bidirectional Mendelian randomization study.

IF 5.9 2区 医学 Q1 IMMUNOLOGY Frontiers in Immunology Pub Date : 2023-01-04 eCollection Date: 2022-01-01 DOI:10.3389/fimmu.2022.1057253
Shuai Yuan, Ji Hun Kim, Pai Xu, Zhao Wang
{"title":"Causal association between celiac disease and inflammatory bowel disease: A two-sample bidirectional Mendelian randomization study.","authors":"Shuai Yuan, Ji Hun Kim, Pai Xu, Zhao Wang","doi":"10.3389/fimmu.2022.1057253","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>An epidemiological link between celiac disease (CeD) and inflammatory bowel disease (IBD) has been well established recently. In this study, Mendelian randomization (MR) analysis was performed employing pooled data of publicly available genome-wide association studies (GWAS) to determine the causal relationship between CeD and IBD, encompassing ulcerative colitis (UC) and Crohn's disease (CD).</p><p><strong>Methods: </strong>Dataset of CeD was acquired from GWAS for 12,041 cases and 12,228 controls. A GWAS of more than 86,000 patients and controls was used to identify genetic variations underlying IBD. MR analyses were performed with an inverse-variance-weighted approach, an MR-Egger regression, a weighted-mode approach, a weighted-median method, and sensitivity analyses of MR pleiotropy residual sum and outlie (MR-PRESSO).</p><p><strong>Results: </strong>MR demonstrated that genetic predisposition to CeD was linked to a augmented risk of IBD (OR: 1.1408; 95% CI: 1.0614-1.2261; <i>P</i> = 0.0003). In the analysis of the two IBD subtypes, genetic predisposition to CeD was also linked to increased risks of UC (OR: 1.1646; 95% CI: 1.0614-1.2779; <i>P</i> = 0.0012) and CD (OR: 1.1865; 95% CI: 1.0948-1.2859; P = 3.07E-05). Reverse MR analysis results revealed that genetic susceptibility to IBD and CD was correlated with an augmented risk of CeD. However, there was no genetic correlation between UC and CeD. All of the above results were validated with other GWAS databases.</p><p><strong>Conclusion: </strong>There is a bidirectional causal relationship of CeD with IBD and CD. However, UC only augments the risk of developing CeD.</p>","PeriodicalId":12622,"journal":{"name":"Frontiers in Immunology","volume":"13 ","pages":"1057253"},"PeriodicalIF":5.9000,"publicationDate":"2023-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845610/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fimmu.2022.1057253","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: An epidemiological link between celiac disease (CeD) and inflammatory bowel disease (IBD) has been well established recently. In this study, Mendelian randomization (MR) analysis was performed employing pooled data of publicly available genome-wide association studies (GWAS) to determine the causal relationship between CeD and IBD, encompassing ulcerative colitis (UC) and Crohn's disease (CD).

Methods: Dataset of CeD was acquired from GWAS for 12,041 cases and 12,228 controls. A GWAS of more than 86,000 patients and controls was used to identify genetic variations underlying IBD. MR analyses were performed with an inverse-variance-weighted approach, an MR-Egger regression, a weighted-mode approach, a weighted-median method, and sensitivity analyses of MR pleiotropy residual sum and outlie (MR-PRESSO).

Results: MR demonstrated that genetic predisposition to CeD was linked to a augmented risk of IBD (OR: 1.1408; 95% CI: 1.0614-1.2261; P = 0.0003). In the analysis of the two IBD subtypes, genetic predisposition to CeD was also linked to increased risks of UC (OR: 1.1646; 95% CI: 1.0614-1.2779; P = 0.0012) and CD (OR: 1.1865; 95% CI: 1.0948-1.2859; P = 3.07E-05). Reverse MR analysis results revealed that genetic susceptibility to IBD and CD was correlated with an augmented risk of CeD. However, there was no genetic correlation between UC and CeD. All of the above results were validated with other GWAS databases.

Conclusion: There is a bidirectional causal relationship of CeD with IBD and CD. However, UC only augments the risk of developing CeD.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
乳糜泻与炎症性肠病之间的因果关系:双样本双向孟德尔随机研究。
背景:乳糜泻(CeD)与炎症性肠病(IBD)之间的流行病学联系近来已得到证实。本研究利用公开的全基因组关联研究(GWAS)的汇总数据进行了孟德尔随机化(MR)分析,以确定乳糜泻与 IBD(包括溃疡性结肠炎(UC)和克罗恩病(CD))之间的因果关系:方法:从 12,041 例病例和 12,228 例对照的 GWAS 中获取 CeD 数据集。通过对 86,000 多例患者和对照进行 GWAS 分析,确定了 IBD 的基因变异。采用逆方差加权法、MR-Egger回归法、加权模式法、加权中值法以及MR多向性残差和外差(MR-PRESSO)敏感性分析进行了MR分析:MR显示,CeD的遗传易感性与IBD风险的增加有关(OR:1.1408;95% CI:1.0614-1.2261;P = 0.0003)。在对两种 IBD 亚型的分析中,CeD 的遗传易感性也与 UC(OR:1.1646;95% CI:1.0614-1.2779;P = 0.0012)和 CD(OR:1.1865;95% CI:1.0948-1.2859;P = 3.07E-05)的风险增加有关。反向 MR 分析结果显示,IBD 和 CD 的遗传易感性与 CeD 风险的增加相关。然而,UC 和 CeD 之间没有遗传相关性。所有上述结果都与其他全球基因组研究数据库进行了验证:结论:CeD 与 IBD 和 CD 存在双向因果关系。结论:CeD 与 IBD 和 CD 存在双向因果关系,但 UC 只会增加罹患 CeD 的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
9.80
自引率
11.00%
发文量
7153
审稿时长
14 weeks
期刊介绍: Frontiers in Immunology is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational and clinical immunology. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. Frontiers in Immunology is the official Journal of the International Union of Immunological Societies (IUIS). Encompassing the entire field of Immunology, this journal welcomes papers that investigate basic mechanisms of immune system development and function, with a particular emphasis given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis.
期刊最新文献
Immunomodulation by glycosylation: bridging glycobiology to adaptive immunity and therapeutic innovation. Case Report: A case of diabetes mellitus and pneumonitis induced by envafolimab treatment in small cell lung cancer. Methodology for a freshly engineered or cryo-preserved 3D tuberculoma bioplatform for studying tuberculosis biology and high-content screening of therapeutics. KDM5C-regulated SIX5 promotes glioblastoma progression through transcriptional activation of UBE2C and enhancement of the Warburg effect. CNS-compartmentalized IgG aggregates and glycosylation in multiple sclerosis contribute to oligoclonal bands and neuronal cytotoxicity.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1